Point-of-care testing is concerned with the immediacy of response, primarily because of the need to act in a life-threatening crisis or to provide counsel in the ongoing management of a chronic disease. There are both clinical, operational and economic benefits that can accrue from this testing modality which may be observed from several perspectives--the patient, the clinician, the healthcare provider, the healthcare purchaser and society. Thus point-of-care testing can improve the management of chronic diseases such as diabetes, compromised coagulation status and epilepsy--both in terms of optimisation of, and compliance with, therapy. There are also life-threatening crises that can be averted by rapid provision of test results. Each of these scenarios can lead to more efficient use of healthcare resources.
No takes yet. Share an insight, caveat, or question.
Christopher P. Price (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: